|
Dr. Langecker has been the Chief Medical Officer since May 1 2006 at DURECT Corporation. Dr. Langecker joins DURECT from Intarcia Therapeutics Inc. where he served as Chief Medical Officer and Vice President Clinical Affairs. He received his doctorate in medical sciences from the Ludwig-Maximilians University in Munich. He trained in hematology and oncology and has extensive experience in developing drugs and biological products in both Europe and the United States. Dr. Langecker was formerly based in Switzerland where he developed a variety of products for Novartis. He came to the U.S. as a Director in Clinical Research for Schering-Plough and as Vice President Clinical Research for Coulter Pharmaceuticals. More recently he served as Vice President of Clinical Affairs for SUGEN Inc. until its merger with Pharmacia & Upjohn. Dr. Langecker has also served as a Director for Xcyte Therapies based in Seattle WA. | 